SE9802937D0 - Novel compounds - Google Patents
Novel compoundsInfo
- Publication number
- SE9802937D0 SE9802937D0 SE9802937A SE9802937A SE9802937D0 SE 9802937 D0 SE9802937 D0 SE 9802937D0 SE 9802937 A SE9802937 A SE 9802937A SE 9802937 A SE9802937 A SE 9802937A SE 9802937 D0 SE9802937 D0 SE 9802937D0
- Authority
- SE
- Sweden
- Prior art keywords
- novel compounds
- triazole
- therapy
- processes
- preparation
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title 1
- PYRFHJUXDGQZPM-UHFFFAOYSA-N 1,2,4-triazole-3-thione Chemical class S=C1N=CN=N1 PYRFHJUXDGQZPM-UHFFFAOYSA-N 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 238000002560 therapeutic procedure Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
- C07D249/10—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D249/12—Oxygen or sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Thiazole And Isothizaole Compounds (AREA)
Priority Applications (8)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE9802937A SE9802937D0 (sv) | 1998-09-01 | 1998-09-01 | Novel compounds |
EP99946526A EP1109790B1 (de) | 1998-09-01 | 1999-08-27 | 1,2,4-triazol-3-thion verbindungen |
JP2000571050A JP2002525281A (ja) | 1998-09-01 | 1999-08-27 | 1,2,4−トリアゾール−3−チオン化合物 |
AT99946526T ATE240303T1 (de) | 1998-09-01 | 1999-08-27 | 1,2,4-triazol-3-thion verbindungen |
PCT/SE1999/001469 WO2000012489A1 (en) | 1998-09-01 | 1999-08-27 | 1, 2, 4-triazole-3-thione compounds |
AU58923/99A AU5892399A (en) | 1998-09-01 | 1999-08-27 | 1, 2, 4-triazole-3-thione compounds |
DE69907926T DE69907926T2 (de) | 1998-09-01 | 1999-08-27 | 1,2,4-triazol-3-thion verbindungen |
US10/006,245 US20020086862A1 (en) | 1998-09-01 | 2001-12-10 | Novel compounds |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE9802937A SE9802937D0 (sv) | 1998-09-01 | 1998-09-01 | Novel compounds |
Publications (1)
Publication Number | Publication Date |
---|---|
SE9802937D0 true SE9802937D0 (sv) | 1998-09-01 |
Family
ID=20412435
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SE9802937A SE9802937D0 (sv) | 1998-09-01 | 1998-09-01 | Novel compounds |
Country Status (8)
Country | Link |
---|---|
US (1) | US20020086862A1 (de) |
EP (1) | EP1109790B1 (de) |
JP (1) | JP2002525281A (de) |
AT (1) | ATE240303T1 (de) |
AU (1) | AU5892399A (de) |
DE (1) | DE69907926T2 (de) |
SE (1) | SE9802937D0 (de) |
WO (1) | WO2000012489A1 (de) |
Families Citing this family (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB2361003A (en) * | 2000-04-07 | 2001-10-10 | Astrazeneca Ab | Novel compounds |
WO2002005814A1 (en) * | 2000-07-18 | 2002-01-24 | Smithkline Beecham Corporation | Use of il-8 receptor antagonists in the treatment of virus infections |
AU2003215549A1 (en) * | 2003-02-03 | 2004-08-30 | Janssen Pharmaceutica N.V. | Mercaptoimidazoles as ccr2 receptor antagonists |
US7276050B2 (en) * | 2004-03-02 | 2007-10-02 | Alan Franklin | Trans-scleral drug delivery method and apparatus |
WO2005097112A2 (en) * | 2004-03-08 | 2005-10-20 | Wyeth | Ion channel modulators |
JP2008509201A (ja) * | 2004-08-11 | 2008-03-27 | ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ | Ccr2受容体アンタゴニストとしてのメルカプトイミダゾール |
WO2006103119A2 (en) * | 2005-04-01 | 2006-10-05 | Galderma Research & Development | Tyrosinase inhibitors, process for the preparation thereof and use thereof in human medicine and also in cosmetics |
FR2883875A1 (fr) * | 2005-04-01 | 2006-10-06 | Galderma Res & Dev | Nouveaux inhibiteurs de la tyrosinase, leur procede de preparation et leur utilisation en medecine humaine ainsi qu'en cosmetique |
CN101902914A (zh) * | 2007-12-19 | 2010-12-01 | 巴斯夫欧洲公司 | 唑基甲基环氧乙烷、其用途以及包含它们的组合物 |
NZ585915A (en) * | 2007-12-19 | 2012-04-27 | Basf Se | Azolylmethyloxiranes, use thereof and agents containing the same |
US20100273651A1 (en) * | 2007-12-19 | 2010-10-28 | Basf Se | Azolylmethyloxiranes, use Thereof and Agents Containing the Same |
TWI487705B (zh) | 2009-12-17 | 2015-06-11 | Lundbeck & Co As H | 作為pde10a酵素抑制劑之雜芳香族芳基三唑衍生物 |
US9505728B2 (en) | 2012-03-09 | 2016-11-29 | Inception 2, Inc. | Triazolone compounds and uses thereof |
SG11201504622PA (en) | 2012-12-20 | 2015-07-30 | Inception 2 Inc | Triazolone compounds and uses thereof |
CN103012233B (zh) * | 2012-12-26 | 2015-08-26 | 华润赛科药业有限责任公司 | 一种n-(氨基硫代甲基)-5-氧代-1-丙基-2-吡咯烷乙酰胺的制备方法 |
KR20160048988A (ko) | 2013-09-06 | 2016-05-04 | 인셉션 2 인코퍼레이티드 | 트라이아졸론 화합물 및 이의 용도 |
WO2024223907A1 (en) * | 2023-04-26 | 2024-10-31 | Universitat De Barcelona | 1,2,4-triazole-3-thione inhibitors of trex2 for use in the treatment of psoriasis, atopic dermatitis or ichthyosis |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TW467902B (en) * | 1996-07-31 | 2001-12-11 | Bristol Myers Squibb Co | Diphenyl heterocycles as potassium channel modulators |
-
1998
- 1998-09-01 SE SE9802937A patent/SE9802937D0/xx unknown
-
1999
- 1999-08-27 AT AT99946526T patent/ATE240303T1/de not_active IP Right Cessation
- 1999-08-27 AU AU58923/99A patent/AU5892399A/en not_active Abandoned
- 1999-08-27 WO PCT/SE1999/001469 patent/WO2000012489A1/en active IP Right Grant
- 1999-08-27 DE DE69907926T patent/DE69907926T2/de not_active Expired - Fee Related
- 1999-08-27 JP JP2000571050A patent/JP2002525281A/ja active Pending
- 1999-08-27 EP EP99946526A patent/EP1109790B1/de not_active Expired - Lifetime
-
2001
- 2001-12-10 US US10/006,245 patent/US20020086862A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
DE69907926D1 (de) | 2003-06-18 |
WO2000012489A1 (en) | 2000-03-09 |
ATE240303T1 (de) | 2003-05-15 |
DE69907926T2 (de) | 2004-02-19 |
EP1109790A1 (de) | 2001-06-27 |
EP1109790B1 (de) | 2003-05-14 |
AU5892399A (en) | 2000-03-21 |
JP2002525281A (ja) | 2002-08-13 |
US20020086862A1 (en) | 2002-07-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69905170D1 (en) | Thiazolopyrimidinderivate | |
SE9704546D0 (sv) | Novel compounds | |
TR200100054T2 (tr) | Paroksetin metansülfonat | |
SE9704545D0 (sv) | Novel compounds | |
SE9704544D0 (sv) | Novel compounds | |
DK0960107T3 (da) | 6-Thiosubstituerede paclitaxeler | |
HK1048990A1 (en) | Novel compounds. | |
SE9802937D0 (sv) | Novel compounds | |
TR200000152T2 (tr) | Yeni bileşikler. | |
YU13301A (sh) | Muskarinski agonisti i antagonisti | |
IL131407A0 (en) | Tetrahydropyrido compounds medicaments containing the same and the use thereof | |
PL340459A1 (en) | Agonists of 5ht1f | |
NO20006699D0 (no) | Forbindelser med veksthormonfrigjörende egenskaper | |
NO20005548D0 (no) | Mykobakterieinhibitorer | |
DE69818492D1 (en) | 7-methylthiooxomethyl- und 7-methylthiodioxomethyl-paclitaxele | |
RS47804A (en) | 1,3-diarylprop-2-en-1-ones, compositions containing same and use thereof | |
NO20021429D0 (no) | 1,4-dioksacykloalkan-2-oner og 1,4-dioksacykloalken-2-oner | |
TWI231815B (en) | Glycopeptide derivatives and pharmaceutical compositions containing the same for use as antibacterial agents | |
PE61999A1 (es) | Compuestos de tetrahidropiridina |